Risk factors for ESBL-positive Escherichia coli urinary tract infections
Fuente:
Redalyc
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artículo científico |
| Langue: | en |
| Publié: |
Asociación Colombiana de Medicina Interna
2022
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1876442650839613440 |
|---|---|
| author | EDUARDO CARCAUSTO-HUAMANÍ |
| author_facet | EDUARDO CARCAUSTO-HUAMANÍ |
| contents | Risk factors for ESBL-positive Escherichia coli urinary tract infections EDUARDO CARCAUSTO-HUAMANÍ DIANA RODRÍGUEZ-HURTADO Medicina case control extended spectrum beta lactamase (ESBL) Objective: to determine the association of prior antibiotic use, prior hospitalizations, prior urinary tract infections, age, sex and comorbidities in adult patients hospitalized with urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.Materials and methods: a case-control study carried out in the hospital setting of private clinics in Lima. Thirty cases and 30 controls were included, with cases defined as hospitalized patients with an ESBL-producing E. coli urinary tract infection diagnosed by urine culture, and controls defined as hospitalized patients without ESBL-producing E. coli infection. Data were taken from incident cases. A bivariate analysis was performed followed by multivariate logistic regression using the significant variables from the bivariate analysis.Results: the associated factors were: prior antibiotic use OR: 261 (22.5-11,017.4), prior hospital ization OR: 4.6 (1.39-16.1), and prior urinary tract infection OR: 36 (6.9-227.2). After adjusting for potential confounding factors using logistic regression, the main statistically significant associated factor was prior antibiotic use, OR: 97.7 (8.4-1,128.3, p<0.000).Conclusion: evidence was found that prior antibiotic use is a risk factor significantly associated with ESBL E. coli urinary tract infections. (Acta Med Colomb 2022; 47. DOI:org.siir.client.entities.ExtLink@14de194). 2022 artículo científico 0120-2448 https://www.redalyc.org/articulo.oa?id=163175162002 https://www.redalyc.org/journal/1631/163175162002/ https://www.redalyc.org/journal/1631/163175162002/html/ https://www.redalyc.org/journal/1631/163175162002/163175162002.epub https://www.redalyc.org/journal/1631/163175162002/movil 10.36104/amc.2022.2131 en http://www.redalyc.org/revista.oa?id=1631 Acta Médica Colombiana application/pdf Asociación Colombiana de Medicina Interna Acta Médica Colombiana (Colombia) Num.2 Vol.47 |
| format | Artículo científico |
| id | redalyc_163175162002 |
| institution | Redalyc |
| language | en |
| publishDate | 2022 |
| publisher | Asociación Colombiana de Medicina Interna |
| spellingShingle | Risk factors for ESBL-positive Escherichia coli urinary tract infections EDUARDO CARCAUSTO-HUAMANÍ Medicina case control extended spectrum beta lactamase (ESBL) Risk factors for ESBL-positive Escherichia coli urinary tract infections EDUARDO CARCAUSTO-HUAMANÍ DIANA RODRÍGUEZ-HURTADO Medicina case control extended spectrum beta lactamase (ESBL) Objective: to determine the association of prior antibiotic use, prior hospitalizations, prior urinary tract infections, age, sex and comorbidities in adult patients hospitalized with urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.Materials and methods: a case-control study carried out in the hospital setting of private clinics in Lima. Thirty cases and 30 controls were included, with cases defined as hospitalized patients with an ESBL-producing E. coli urinary tract infection diagnosed by urine culture, and controls defined as hospitalized patients without ESBL-producing E. coli infection. Data were taken from incident cases. A bivariate analysis was performed followed by multivariate logistic regression using the significant variables from the bivariate analysis.Results: the associated factors were: prior antibiotic use OR: 261 (22.5-11,017.4), prior hospital ization OR: 4.6 (1.39-16.1), and prior urinary tract infection OR: 36 (6.9-227.2). After adjusting for potential confounding factors using logistic regression, the main statistically significant associated factor was prior antibiotic use, OR: 97.7 (8.4-1,128.3, p<0.000).Conclusion: evidence was found that prior antibiotic use is a risk factor significantly associated with ESBL E. coli urinary tract infections. (Acta Med Colomb 2022; 47. DOI:org.siir.client.entities.ExtLink@14de194). 2022 artículo científico 0120-2448 https://www.redalyc.org/articulo.oa?id=163175162002 https://www.redalyc.org/journal/1631/163175162002/ https://www.redalyc.org/journal/1631/163175162002/html/ https://www.redalyc.org/journal/1631/163175162002/163175162002.epub https://www.redalyc.org/journal/1631/163175162002/movil 10.36104/amc.2022.2131 en http://www.redalyc.org/revista.oa?id=1631 Acta Médica Colombiana application/pdf Asociación Colombiana de Medicina Interna Acta Médica Colombiana (Colombia) Num.2 Vol.47 |
| title | Risk factors for ESBL-positive Escherichia coli urinary tract infections |
| topic | Medicina case control extended spectrum beta lactamase (ESBL) |
| url | https://www.redalyc.org/articulo.oa?id=163175162002 https://www.redalyc.org/journal/1631/163175162002/ https://www.redalyc.org/journal/1631/163175162002/html/ https://www.redalyc.org/journal/1631/163175162002/163175162002.epub https://www.redalyc.org/journal/1631/163175162002/movil |